NCT02616133View on ClinicalTrials.gov

HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Breast Cancer
Interventions
OTHER

chart abstraction

abstraction of breast cancer patients with de-identified data

Trial Locations (4)

27536

DLP Maria Parham Medical Center, Henderson

29169

Lexington Medical Center, West Columbia

49855

Marquette General Hospital, Marquette

Unknown

Augusta Health, Fishersville

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER

NCT02616133 - HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program | Biotech Hunter | Biotech Hunter